Evidence map›Paper›PMID 25267885›Full record

ArticleJournal of food and drug analysis2013

Genetics and pharmacogenetics of substance use disorders.

Pao-Luh Tao, Li-Shiun Chen, Chih-Ken Chen, Yu-Li Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of food and drug analysis, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pao-Luh TaoCenter for Neuropsychiatric Research, National Health Research Institutes, Taiwan, Republic of China.
Li-Shiun ChenDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Chih-Ken ChenDepartment of Psychiatry, Chang Gung Memorial Hospital, Taiwan, Republic of China.
Yu-Li LiuCenter for Neuropsychiatric Research, National Health Research Institutes, Taiwan, Republic of China.

Funding

STATISTICAL SUPPORT/DATA MANAGEMENT COREP30DA016383 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HSER, YIH-ING · 2005 to 2015
$8.6M
Genetic and Environmental Risks for Smoking Characteristics and CessationK08DA030398 · NIDA · WASHINGTON UNIVERSITY · PI CHEN, LI-SHIUN · 2011 to 2014
$671k
Conference Series to Promote Global Health...R13DA035084 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HSER, YIH-ING · 2013 to 2017
$143k
NIDA NIH HHS K08 DA030398NIDA NIH HHS P30 DA016383NIDA NIH HHS R13 DA035084
6 · The paper itself

Abstract

The "Genetics and Pharmacogenetics of Substance Use Disorder" session was chaired by Dr. Pao-Luh Tao and had three speakers. The speakers and their topics were: Dr. Li-Shiun Chen presented on Genomics and Personalized Medicine for Smoking Cessation Treatments, Dr. Chih-Ken Chen presented on the Genetics of Methamphetamine Abuse and Methamphetamine Psychosis, and Dr. Yu-Li Liu presented on a Pharmacogenomics Study in a Taiwan Methadone Maintenance Cohort.

Indexed as

geneticsmethadonemethamphetaminepharmacogeneticssmoking cessationsubstance use disorders

Identifiers

PMID25267885
PMCPMC4176940

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.